pyridostigmine bromide has been researched along with Labhart-Willi Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocchini, S; Cappa, M; Crinò, A; Cuttini, M; Di Giorgio, G; Fintini, D; Grugni, G; Spera, S | 1 |
| Bellone, J; Benedetti, S; Borrelli, P; Cappa, M; Carta, D; Ghigo, E; Grossi, A; Loche, S | 1 |
| Beccaria, L; Benzi, F; Bosio, L; Brambilla, P; Chiumello, G; Sanzari, A | 1 |
| Bettio, D; De Medici, C; Grugni, G; Guzzaloni, G; Morabito, F; Moro, D | 1 |
| Grugni, G; Guzzaloni, G; Morabito, F | 1 |
1 trial(s) available for pyridostigmine bromide and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Arginine; Child, Preschool; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Male; Prader-Willi Syndrome; Pyridostigmine Bromide | 2014 |
4 other study(ies) available for pyridostigmine bromide and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome.
Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1993 |
Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Child; Cholinesterase Inhibitors; Clonidine; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Prader-Willi Syndrome; Pyridostigmine Bromide; Sermorelin | 1996 |
Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
Topics: Adolescent; Adult; Child; Cholinesterase Inhibitors; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Obesity; Prader-Willi Syndrome; Pyridostigmine Bromide | 1998 |
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
Topics: Adolescent; Adult; Body Mass Index; Child; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Kinetics; Male; Obesity; Oligopeptides; Prader-Willi Syndrome; Pyridostigmine Bromide | 2001 |